Review of direct-acting antiviral agents for the treatment of chronic hepatitis C

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.9, 2013-09, pp. : 1107-1121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 7, 2018-03 ,pp. : 584-596

Bentham Science Publishers

Access to resources Recommend Favorite

Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

Blackwell Publishing

Access to resources Recommend Favorite

Direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4268-4269

Blackwell Publishing

Access to resources Recommend Favorite

Antiviral Therapy for Chronic Hepatitis B: A Review

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-01 ,pp. : 63-70

Bentham Science Publishers

Access to resources Recommend Favorite

Taribavirin for the treatment of chronic hepatitis C

By Kearney Keith R Thornton James J Navarro Victor J

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3243-3249

Informa Healthcare

Access to resources Recommend Favorite